Table 3 summarizes evidence on the molecular mechanisms implicated in the ameliorative effects of NAC against lipid accumulation, oxidative stress, and inflammation in knockout models of NAFLD. This evidence concerns the gene NLRP1 and metabolic dysfunction-associated steatotic liver disease.